Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction (Q40207574)
Jump to navigation
Jump to search
scientific article published on July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction |
scientific article published on July 2007 |
Statements
1 reference
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction (English)
1 reference
Melanoma Study Group of the Mayo Clinic Cancer Center
1 reference
Esteban Celis
1 reference
1 July 2007
1 reference
1 reference
110
1 reference
1
1 reference
203-214
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference